Why is Pseudomonas aeruginosa a common cause of infection in individuals with cystic fibrosis?

被引：0
作者：
Gross, Jeremy [1 ]
Welch, Martin [1 ]
机构：
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England
来源：
FUTURE MICROBIOLOGY | 2013年 / 8卷 / 06期
基金：
英国生物技术与生命科学研究理事会;
关键词：
antibiotic resistance; cystic fibrosis; microbial adaptation; Pseudomonas aeruginosa; BIOFILMS;
D O I：
10.2217/FMB.13.40
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：697 / 699
页数：3
相关论文
共 50 条
  • [21] Pseudomonas aeruginosa in cystic fibrosis:: cross-infection and the need for segregation
    Tubbs, D
    Lenney, W
    Alcock, P
    Campbell, CA
    Gray, J
    Pantin, C
    RESPIRATORY MEDICINE, 2001, 95 (02) : 147 - 152
  • [22] Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis
    Ledger, Emma L.
    Smith, Daniel J.
    Teh, Jing Jie
    Wood, Michelle E.
    Whibley, Page E.
    Morrison, Mark
    Goldberg, Joanna B.
    Reid, David W.
    Wells, Timothy J.
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (03) : e536 - e547
  • [23] Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection
    Pukhalsky, AL
    Kapranov, NI
    Kalashnikova, EA
    Shmarina, GV
    Shabalova, LA
    Kokarovtseva, SN
    Pukhalskaya, DA
    Kashirskaja, NJ
    Simonova, OI
    MEDIATORS OF INFLAMMATION, 1999, 8 (03) : 159 - 167
  • [24] Prophylaxis and therapy of Pseudomonas aeruginosa infection in cystic fibrosis and immunocompromised patients
    Lang, AB
    Horn, MP
    Imboden, MA
    Zuercher, AW
    VACCINE, 2004, 22 : S44 - S48
  • [25] Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection
    Giordano, A
    Magni, A
    Filadoro, F
    Graziani, C
    Quattrucci, S
    Cipriani, P
    MICROBIOLOGICA, 1998, 21 (04): : 375 - 378
  • [26] Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis
    Ratjen, Felix
    CURRENT OPINION IN PULMONARY MEDICINE, 2006, 12 (06) : 428 - 432
  • [27] Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection
    J E Park
    R Yung
    D Stefanowicz
    K Shumansky
    L Akhabir
    P R Durie
    M Corey
    J Zielenski
    R Dorfman
    D Daley
    A J Sandford
    Genes & Immunity, 2011, 12 : 370 - 377
  • [28] Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection
    Park, J. E.
    Yung, R.
    Stefanowicz, D.
    Shumansky, K.
    Akhabir, L.
    Durie, P. R.
    Corey, M.
    Zielenski, J.
    Dorfman, R.
    Daley, D.
    Sandford, A. J.
    GENES AND IMMUNITY, 2011, 12 (05) : 370 - 377
  • [29] Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis
    Bilton, Diana
    Pressler, Tacjana
    Fajac, Isabelle
    Clancy, John Paul
    Sands, Dorota
    Minic, Predrag
    Cipolli, Marco
    Galeva, Ivanka
    Sole, Amparo
    Quittner, Alexandra L.
    Liu, Keith
    McGinnis, John R., II
    Eagle, Gina
    Gupta, Renu
    Konstan, Michael W.
    JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (02) : 284 - 291
  • [30] Novel conjugate vaccine for the prevention of pseudomonas aeruginosa infection in cystic fibrosis patients
    Matson, Kelly L.
    Bratberg, Jeffrey P.
    DRUG DEVELOPMENT RESEARCH, 2007, 68 (08) : 512 - 521
12345